← Back to Search

SMS-Web eAAP group for Asthma (asthma Trial)

N/A
Waitlist Available
Led By Mark J FitzGerald, M.D.
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up number of asthma exacerbations will be assessed by global initiative for asthma (gina) standard assessment tool for 12 months post-intervention
Awards & highlights

asthma Trial Summary

Objectives: The disease being studied is asthma. The main objective of this study is to assess the feasibility of the recruitment goals and also the logistical issues related to use of tele-health technology in developing electronic asthma action plan (eAAP) and communicate with asthma patients in a time period of 24 months. The goals are: 1) enable asthma patients to self-manage their asthma symptoms. The secondary, 2) help care providers to intervene appropriately based on the patient's health status. The secondary objective is to explore the cost-benefit and cost-effectiveness of the proposed technology. Our research group proposes to complete a feasibility study, with an interim analysis for a formal power calculation and then acquire ethics to report these results and study design with anticipated publication prior to proceeding with a full randomized controlled trial to assess the efficacy of this intervention. The outcome measure will be assessed and data will be presented in a 24-month time frame. Aims and goals: The main aim of our proposed study is to assist asthma patients to practice asthma self-management at home that will eventually enable them to control their asthma, and specifically, prevent asthma exacerbation. Therefore, the ultimate goal of our proposed study is to improve patient health outcome via enhancing patient-physician interaction and using a more practical asthma action plan model (eAAP) that could be followed easily by the patient and their doctor. Our hypothesis is that asthma patients who have access to the electronic online action plan complimented by weekly text messages to reinforce adherence will have a reduced rate of asthma exacerbation. We further hypothesize that these subjects will have an improvement in secondary measures including quality of life, better asthma control and patient satisfaction. We also anticipate that such an approach in asthma management will be cost-effective as outlined below.

Eligible Conditions
  • Asthma

asthma Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~economic outcomes will be collected during the follow-up period (12 months after intervention). cost-effectiveness will be assessed through decision-analytic modeling.
This trial's timeline: 3 weeks for screening, Varies for treatment, and economic outcomes will be collected during the follow-up period (12 months after intervention). cost-effectiveness will be assessed through decision-analytic modeling. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduction in the rate of asthma exacerbations
Secondary outcome measures
the cost-effectiveness and cost-benefit of applying the SMS and web combination technology

asthma Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SMS-Web eAAP groupExperimental Treatment1 Intervention
electronic asthma action plan (eAAP) group
Group II: regular-care groupActive Control1 Intervention
written asthma action plan (WAAP) group

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,413 Previous Clinical Trials
2,466,861 Total Patients Enrolled
16 Trials studying Asthma
3,696 Patients Enrolled for Asthma
PfizerIndustry Sponsor
4,567 Previous Clinical Trials
10,911,773 Total Patients Enrolled
39 Trials studying Asthma
62,035 Patients Enrolled for Asthma
Providence Health & ServicesOTHER
117 Previous Clinical Trials
822,435 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~9 spots leftby Apr 2025